Elutia Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.08

+0.03 (+2.86%)

As of Apr 1, 3:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +925.0% upside

Low Target $6.75

Average Target $11.07

High Target $12.78

Current Price $1.08

Current
$1.08

Target
$11.07

$6.75 $11.07 avg $12.78

Scenario Analysis

Bear Case

$6.75

525.0%

Low target

Base Case

$11.07

+925.0%

Avg target

Bull Case

$12.78

+1,083.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.99

-63.9% from high

52-Week Low

$0.50

+116.0% from low

Target vs 52W High

$11.07

+270.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%